Global Adipose Tissue-derived Stem Cell Therapy Supply, Demand and Key Producers, 2023-2029

Description

The global Adipose Tissue-derived Stem Cell Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Adipose tissue stem cells (ASCs), known as multipotent stem cells, are most commonly used in the clinical applications in recent years.

This report studies the global Adipose Tissue-derived Stem Cell Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Adipose Tissue-derived Stem Cell Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Adipose Tissue-derived Stem Cell Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Adipose Tissue-derived Stem Cell Therapy total market, 2018-2029, (USD Million)
Global Adipose Tissue-derived Stem Cell Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Adipose Tissue-derived Stem Cell Therapy total market, key domestic companies and share, (USD Million)
Global Adipose Tissue-derived Stem Cell Therapy revenue by player and market share 2018-2023, (USD Million)
Global Adipose Tissue-derived Stem Cell Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Adipose Tissue-derived Stem Cell Therapy total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Adipose Tissue-derived Stem Cell Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AlloCure, Antria, Celgene Corporation, Cellleris, Corestem, Cytori Therapeutics, Intrexon, Mesoblast and Pluristem Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Adipose Tissue-derived Stem Cell Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Adipose Tissue-derived Stem Cell Therapy Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Adipose Tissue-derived Stem Cell Therapy Market, Segmentation by Type
    Autologous Stem Cells
    Allogeneic Stem Cells

Global Adipose Tissue-derived Stem Cell Therapy Market, Segmentation by Application
    Therapeutic Application
    Research Application

Companies Profiled:
    AlloCure
    Antria
    Celgene Corporation
    Cellleris
    Corestem
    Cytori Therapeutics
    Intrexon
    Mesoblast
    Pluristem Therapeutics
    Tissue Genesis
    BioRestorative Therapies
    Celltex Therapeutics Corporation
    iXCells Biotechnologies
    Pluristem Therapeutics
    Cyagen
    Lonza

Key Questions Answered
1. How big is the global Adipose Tissue-derived Stem Cell Therapy market?
2. What is the demand of the global Adipose Tissue-derived Stem Cell Therapy market?
3. What is the year over year growth of the global Adipose Tissue-derived Stem Cell Therapy market?
4. What is the total value of the global Adipose Tissue-derived Stem Cell Therapy market?
5. Who are the major players in the global Adipose Tissue-derived Stem Cell Therapy market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Adipose Tissue-derived Stem Cell Therapy Introduction
    1.2 World Adipose Tissue-derived Stem Cell Therapy Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Adipose Tissue-derived Stem Cell Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Adipose Tissue-derived Stem Cell Therapy Market Size (2018-2029)
        1.3.3 China Adipose Tissue-derived Stem Cell Therapy Market Size (2018-2029)
        1.3.4 Europe Adipose Tissue-derived Stem Cell Therapy Market Size (2018-2029)
        1.3.5 Japan Adipose Tissue-derived Stem Cell Therapy Market Size (2018-2029)
        1.3.6 South Korea Adipose Tissue-derived Stem Cell Therapy Market Size (2018-2029)
        1.3.7 ASEAN Adipose Tissue-derived Stem Cell Therapy Market Size (2018-2029)
        1.3.8 India Adipose Tissue-derived Stem Cell Therapy Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Adipose Tissue-derived Stem Cell Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Adipose Tissue-derived Stem Cell Therapy Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029)
    2.2 World Adipose Tissue-derived Stem Cell Therapy Consumption Value by Region
        2.2.1 World Adipose Tissue-derived Stem Cell Therapy Consumption Value by Region (2018-2023)
        2.2.2 World Adipose Tissue-derived Stem Cell Therapy Consumption Value Forecast by Region (2024-2029)
    2.3 United States Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029)
    2.4 China Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029)
    2.5 Europe Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029)
    2.6 Japan Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029)
    2.7 South Korea Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029)
    2.8 ASEAN Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029)
    2.9 India Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029)

3 World Adipose Tissue-derived Stem Cell Therapy Companies Competitive Analysis
    3.1 World Adipose Tissue-derived Stem Cell Therapy Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Adipose Tissue-derived Stem Cell Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Adipose Tissue-derived Stem Cell Therapy in 2022
        3.2.3 Global Concentration Ratios (CR8) for Adipose Tissue-derived Stem Cell Therapy in 2022
    3.3 Adipose Tissue-derived Stem Cell Therapy Company Evaluation Quadrant
    3.4 Adipose Tissue-derived Stem Cell Therapy Market: Overall Company Footprint Analysis
        3.4.1 Adipose Tissue-derived Stem Cell Therapy Market: Region Footprint
        3.4.2 Adipose Tissue-derived Stem Cell Therapy Market: Company Product Type Footprint
        3.4.3 Adipose Tissue-derived Stem Cell Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Adipose Tissue-derived Stem Cell Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Adipose Tissue-derived Stem Cell Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Adipose Tissue-derived Stem Cell Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Adipose Tissue-derived Stem Cell Therapy Consumption Value Comparison
        4.2.1 United States VS China: Adipose Tissue-derived Stem Cell Therapy Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Adipose Tissue-derived Stem Cell Therapy Companies and Market Share, 2018-2023
        4.3.1 United States Based Adipose Tissue-derived Stem Cell Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Adipose Tissue-derived Stem Cell Therapy Revenue, (2018-2023)
    4.4 China Based Companies Adipose Tissue-derived Stem Cell Therapy Revenue and Market Share, 2018-2023
        4.4.1 China Based Adipose Tissue-derived Stem Cell Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Adipose Tissue-derived Stem Cell Therapy Revenue, (2018-2023)
    4.5 Rest of World Based Adipose Tissue-derived Stem Cell Therapy Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Adipose Tissue-derived Stem Cell Therapy Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Adipose Tissue-derived Stem Cell Therapy Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Adipose Tissue-derived Stem Cell Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Autologous Stem Cells
        5.2.2 Allogeneic Stem Cells
    5.3 Market Segment by Type
        5.3.1 World Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2018-2023)
        5.3.2 World Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2024-2029)
        5.3.3 World Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Adipose Tissue-derived Stem Cell Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Therapeutic Application
        6.2.2 Research Application
    6.3 Market Segment by Application
        6.3.1 World Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2018-2023)
        6.3.2 World Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2024-2029)
        6.3.3 World Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2018-2029)

7 Company Profiles
    7.1 AlloCure
        7.1.1 AlloCure Details
        7.1.2 AlloCure Major Business
        7.1.3 AlloCure Adipose Tissue-derived Stem Cell Therapy Product and Services
        7.1.4 AlloCure Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 AlloCure Recent Developments/Updates
        7.1.6 AlloCure Competitive Strengths & Weaknesses
    7.2 Antria
        7.2.1 Antria Details
        7.2.2 Antria Major Business
        7.2.3 Antria Adipose Tissue-derived Stem Cell Therapy Product and Services
        7.2.4 Antria Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Antria Recent Developments/Updates
        7.2.6 Antria Competitive Strengths & Weaknesses
    7.3 Celgene Corporation
        7.3.1 Celgene Corporation Details
        7.3.2 Celgene Corporation Major Business
        7.3.3 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product and Services
        7.3.4 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Celgene Corporation Recent Developments/Updates
        7.3.6 Celgene Corporation Competitive Strengths & Weaknesses
    7.4 Cellleris
        7.4.1 Cellleris Details
        7.4.2 Cellleris Major Business
        7.4.3 Cellleris Adipose Tissue-derived Stem Cell Therapy Product and Services
        7.4.4 Cellleris Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Cellleris Recent Developments/Updates
        7.4.6 Cellleris Competitive Strengths & Weaknesses
    7.5 Corestem
        7.5.1 Corestem Details
        7.5.2 Corestem Major Business
        7.5.3 Corestem Adipose Tissue-derived Stem Cell Therapy Product and Services
        7.5.4 Corestem Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Corestem Recent Developments/Updates
        7.5.6 Corestem Competitive Strengths & Weaknesses
    7.6 Cytori Therapeutics
        7.6.1 Cytori Therapeutics Details
        7.6.2 Cytori Therapeutics Major Business
        7.6.3 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product and Services
        7.6.4 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Cytori Therapeutics Recent Developments/Updates
        7.6.6 Cytori Therapeutics Competitive Strengths & Weaknesses
    7.7 Intrexon
        7.7.1 Intrexon Details
        7.7.2 Intrexon Major Business
        7.7.3 Intrexon Adipose Tissue-derived Stem Cell Therapy Product and Services
        7.7.4 Intrexon Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Intrexon Recent Developments/Updates
        7.7.6 Intrexon Competitive Strengths & Weaknesses
    7.8 Mesoblast
        7.8.1 Mesoblast Details
        7.8.2 Mesoblast Major Business
        7.8.3 Mesoblast Adipose Tissue-derived Stem Cell Therapy Product and Services
        7.8.4 Mesoblast Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Mesoblast Recent Developments/Updates
        7.8.6 Mesoblast Competitive Strengths & Weaknesses
    7.9 Pluristem Therapeutics
        7.9.1 Pluristem Therapeutics Details
        7.9.2 Pluristem Therapeutics Major Business
        7.9.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product and Services
        7.9.4 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Pluristem Therapeutics Recent Developments/Updates
        7.9.6 Pluristem Therapeutics Competitive Strengths & Weaknesses
    7.10 Tissue Genesis
        7.10.1 Tissue Genesis Details
        7.10.2 Tissue Genesis Major Business
        7.10.3 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product and Services
        7.10.4 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Tissue Genesis Recent Developments/Updates
        7.10.6 Tissue Genesis Competitive Strengths & Weaknesses
    7.11 BioRestorative Therapies
        7.11.1 BioRestorative Therapies Details
        7.11.2 BioRestorative Therapies Major Business
        7.11.3 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product and Services
        7.11.4 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 BioRestorative Therapies Recent Developments/Updates
        7.11.6 BioRestorative Therapies Competitive Strengths & Weaknesses
    7.12 Celltex Therapeutics Corporation
        7.12.1 Celltex Therapeutics Corporation Details
        7.12.2 Celltex Therapeutics Corporation Major Business
        7.12.3 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product and Services
        7.12.4 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Celltex Therapeutics Corporation Recent Developments/Updates
        7.12.6 Celltex Therapeutics Corporation Competitive Strengths & Weaknesses
    7.13 iXCells Biotechnologies
        7.13.1 iXCells Biotechnologies Details
        7.13.2 iXCells Biotechnologies Major Business
        7.13.3 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product and Services
        7.13.4 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 iXCells Biotechnologies Recent Developments/Updates
        7.13.6 iXCells Biotechnologies Competitive Strengths & Weaknesses
    7.14 Pluristem Therapeutics
        7.14.1 Pluristem Therapeutics Details
        7.14.2 Pluristem Therapeutics Major Business
        7.14.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product and Services
        7.14.4 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Pluristem Therapeutics Recent Developments/Updates
        7.14.6 Pluristem Therapeutics Competitive Strengths & Weaknesses
    7.15 Cyagen
        7.15.1 Cyagen Details
        7.15.2 Cyagen Major Business
        7.15.3 Cyagen Adipose Tissue-derived Stem Cell Therapy Product and Services
        7.15.4 Cyagen Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Cyagen Recent Developments/Updates
        7.15.6 Cyagen Competitive Strengths & Weaknesses
    7.16 Lonza
        7.16.1 Lonza Details
        7.16.2 Lonza Major Business
        7.16.3 Lonza Adipose Tissue-derived Stem Cell Therapy Product and Services
        7.16.4 Lonza Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 Lonza Recent Developments/Updates
        7.16.6 Lonza Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Adipose Tissue-derived Stem Cell Therapy Industry Chain
    8.2 Adipose Tissue-derived Stem Cell Therapy Upstream Analysis
    8.3 Adipose Tissue-derived Stem Cell Therapy Midstream Analysis
    8.4 Adipose Tissue-derived Stem Cell Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Adipose Tissue-derived Stem Cell Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Adipose Tissue-derived Stem Cell Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Adipose Tissue-derived Stem Cell Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Adipose Tissue-derived Stem Cell Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Adipose Tissue-derived Stem Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Adipose Tissue-derived Stem Cell Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Adipose Tissue-derived Stem Cell Therapy Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Adipose Tissue-derived Stem Cell Therapy Players in 2022
    Table 12. World Adipose Tissue-derived Stem Cell Therapy Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Adipose Tissue-derived Stem Cell Therapy Company Evaluation Quadrant
    Table 14. Head Office of Key Adipose Tissue-derived Stem Cell Therapy Player
    Table 15. Adipose Tissue-derived Stem Cell Therapy Market: Company Product Type Footprint
    Table 16. Adipose Tissue-derived Stem Cell Therapy Market: Company Product Application Footprint
    Table 17. Adipose Tissue-derived Stem Cell Therapy Mergers & Acquisitions Activity
    Table 18. United States VS China Adipose Tissue-derived Stem Cell Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Adipose Tissue-derived Stem Cell Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Adipose Tissue-derived Stem Cell Therapy Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Adipose Tissue-derived Stem Cell Therapy Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Adipose Tissue-derived Stem Cell Therapy Revenue Market Share (2018-2023)
    Table 23. China Based Adipose Tissue-derived Stem Cell Therapy Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Adipose Tissue-derived Stem Cell Therapy Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Adipose Tissue-derived Stem Cell Therapy Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Adipose Tissue-derived Stem Cell Therapy Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Adipose Tissue-derived Stem Cell Therapy Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Adipose Tissue-derived Stem Cell Therapy Revenue Market Share (2018-2023)
    Table 29. World Adipose Tissue-derived Stem Cell Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Adipose Tissue-derived Stem Cell Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2024-2029) & (USD Million)
    Table 35. AlloCure Basic Information, Area Served and Competitors
    Table 36. AlloCure Major Business
    Table 37. AlloCure Adipose Tissue-derived Stem Cell Therapy Product and Services
    Table 38. AlloCure Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. AlloCure Recent Developments/Updates
    Table 40. AlloCure Competitive Strengths & Weaknesses
    Table 41. Antria Basic Information, Area Served and Competitors
    Table 42. Antria Major Business
    Table 43. Antria Adipose Tissue-derived Stem Cell Therapy Product and Services
    Table 44. Antria Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Antria Recent Developments/Updates
    Table 46. Antria Competitive Strengths & Weaknesses
    Table 47. Celgene Corporation Basic Information, Area Served and Competitors
    Table 48. Celgene Corporation Major Business
    Table 49. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product and Services
    Table 50. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Celgene Corporation Recent Developments/Updates
    Table 52. Celgene Corporation Competitive Strengths & Weaknesses
    Table 53. Cellleris Basic Information, Area Served and Competitors
    Table 54. Cellleris Major Business
    Table 55. Cellleris Adipose Tissue-derived Stem Cell Therapy Product and Services
    Table 56. Cellleris Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Cellleris Recent Developments/Updates
    Table 58. Cellleris Competitive Strengths & Weaknesses
    Table 59. Corestem Basic Information, Area Served and Competitors
    Table 60. Corestem Major Business
    Table 61. Corestem Adipose Tissue-derived Stem Cell Therapy Product and Services
    Table 62. Corestem Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Corestem Recent Developments/Updates
    Table 64. Corestem Competitive Strengths & Weaknesses
    Table 65. Cytori Therapeutics Basic Information, Area Served and Competitors
    Table 66. Cytori Therapeutics Major Business
    Table 67. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product and Services
    Table 68. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Cytori Therapeutics Recent Developments/Updates
    Table 70. Cytori Therapeutics Competitive Strengths & Weaknesses
    Table 71. Intrexon Basic Information, Area Served and Competitors
    Table 72. Intrexon Major Business
    Table 73. Intrexon Adipose Tissue-derived Stem Cell Therapy Product and Services
    Table 74. Intrexon Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Intrexon Recent Developments/Updates
    Table 76. Intrexon Competitive Strengths & Weaknesses
    Table 77. Mesoblast Basic Information, Area Served and Competitors
    Table 78. Mesoblast Major Business
    Table 79. Mesoblast Adipose Tissue-derived Stem Cell Therapy Product and Services
    Table 80. Mesoblast Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Mesoblast Recent Developments/Updates
    Table 82. Mesoblast Competitive Strengths & Weaknesses
    Table 83. Pluristem Therapeutics Basic Information, Area Served and Competitors
    Table 84. Pluristem Therapeutics Major Business
    Table 85. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product and Services
    Table 86. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Pluristem Therapeutics Recent Developments/Updates
    Table 88. Pluristem Therapeutics Competitive Strengths & Weaknesses
    Table 89. Tissue Genesis Basic Information, Area Served and Competitors
    Table 90. Tissue Genesis Major Business
    Table 91. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product and Services
    Table 92. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Tissue Genesis Recent Developments/Updates
    Table 94. Tissue Genesis Competitive Strengths & Weaknesses
    Table 95. BioRestorative Therapies Basic Information, Area Served and Competitors
    Table 96. BioRestorative Therapies Major Business
    Table 97. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product and Services
    Table 98. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. BioRestorative Therapies Recent Developments/Updates
    Table 100. BioRestorative Therapies Competitive Strengths & Weaknesses
    Table 101. Celltex Therapeutics Corporation Basic Information, Area Served and Competitors
    Table 102. Celltex Therapeutics Corporation Major Business
    Table 103. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product and Services
    Table 104. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Celltex Therapeutics Corporation Recent Developments/Updates
    Table 106. Celltex Therapeutics Corporation Competitive Strengths & Weaknesses
    Table 107. iXCells Biotechnologies Basic Information, Area Served and Competitors
    Table 108. iXCells Biotechnologies Major Business
    Table 109. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product and Services
    Table 110. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. iXCells Biotechnologies Recent Developments/Updates
    Table 112. iXCells Biotechnologies Competitive Strengths & Weaknesses
    Table 113. Pluristem Therapeutics Basic Information, Area Served and Competitors
    Table 114. Pluristem Therapeutics Major Business
    Table 115. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product and Services
    Table 116. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Pluristem Therapeutics Recent Developments/Updates
    Table 118. Pluristem Therapeutics Competitive Strengths & Weaknesses
    Table 119. Cyagen Basic Information, Area Served and Competitors
    Table 120. Cyagen Major Business
    Table 121. Cyagen Adipose Tissue-derived Stem Cell Therapy Product and Services
    Table 122. Cyagen Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Cyagen Recent Developments/Updates
    Table 124. Lonza Basic Information, Area Served and Competitors
    Table 125. Lonza Major Business
    Table 126. Lonza Adipose Tissue-derived Stem Cell Therapy Product and Services
    Table 127. Lonza Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 128. Global Key Players of Adipose Tissue-derived Stem Cell Therapy Upstream (Raw Materials)
    Table 129. Adipose Tissue-derived Stem Cell Therapy Typical Customers
List of Figure
    Figure 1. Adipose Tissue-derived Stem Cell Therapy Picture
    Figure 2. World Adipose Tissue-derived Stem Cell Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Adipose Tissue-derived Stem Cell Therapy Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Adipose Tissue-derived Stem Cell Therapy Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Adipose Tissue-derived Stem Cell Therapy Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Adipose Tissue-derived Stem Cell Therapy Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Adipose Tissue-derived Stem Cell Therapy Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Adipose Tissue-derived Stem Cell Therapy Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Adipose Tissue-derived Stem Cell Therapy Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Adipose Tissue-derived Stem Cell Therapy Revenue (2018-2029) & (USD Million)
    Figure 13. Adipose Tissue-derived Stem Cell Therapy Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Adipose Tissue-derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Adipose Tissue-derived Stem Cell Therapy by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Adipose Tissue-derived Stem Cell Therapy Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Adipose Tissue-derived Stem Cell Therapy Markets in 2022
    Figure 27. United States VS China: Adipose Tissue-derived Stem Cell Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Adipose Tissue-derived Stem Cell Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Adipose Tissue-derived Stem Cell Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type in 2022
    Figure 31. Autologous Stem Cells
    Figure 32. Allogeneic Stem Cells
    Figure 33. World Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2018-2029)
    Figure 34. World Adipose Tissue-derived Stem Cell Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2022
    Figure 36. Therapeutic Application
    Figure 37. Research Application
    Figure 38. Adipose Tissue-derived Stem Cell Therapy Industrial Chain
    Figure 39. Methodology
    Figure 40. Research Process and Data Source

Companies Mentioned

AlloCure
Antria
Celgene Corporation
Cellleris
Corestem
Cytori Therapeutics
Intrexon
Mesoblast
Pluristem Therapeutics
Tissue Genesis
BioRestorative Therapies
Celltex Therapeutics Corporation
iXCells Biotechnologies
Pluristem Therapeutics
Cyagen
Lonza